A 57-year-old with type 2 diabetes and symptomatic HFrEF (EF 35%) is not on SGLT2 therapy. According to HF and diabetes guidance, adding which agent r...

Question

A 57-year-old with type 2 diabetes and symptomatic HFrEF (EF 35%) is not on SGLT2 therapy. According to HF and diabetes guidance, adding which agent reduces HF hospitalization and CV events?

Accepted Answer

SGLT2 inhibitor

Answer

DPP-4 inhibitor

Answer

GLP-1 receptor agonist only

Answer

Thiazolidinedione

Answer

Glycemic control only

"hf in diabetes" MCQ (SBA): Heart Failure with reduced Ejection Fraction (HFrEF) and Type 2 Diabetes

A 57-year-old with type 2 diabetes and symptomatic HFrEF (EF 35%) is not on SGLT2 therapy. According to HF and diabetes guidance, adding which agent reduces HF hospitalization and CV events?